Electra Therapeutics, Inc. (ETRA) News
Follow Electra Therapeutics, Inc. (ETRA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake
OrbiMed Advisors LLC disclosed an 11.0% stake in Electra Therapeutics, Inc. common stock. The filing, dated September 25, 2026, follows Electra Therapeutics’ IPO and the conversion of preferred shares into common stock.
EQUITY | Sep 25, 2026, 09:39 PM UTC
L
ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO
Shares of ADARx Pharmaceuticals (ADRX.O) rose 30% above their initial public offering price on Friday after the late-stage gene therapy developer raised $446.3 million in an upsized US initial public offering.The shares
EQUITY | Sep 25, 2026, 04:21 PM UTC
L
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO
ADARx Pharmaceuticals (ADRX.O) said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings.The San Diego-based drug developer sold 26.
EQUITY | Sep 25, 2026, 11:02 AM UTC
L
ETRA - IPO Open
ETRA - IPO Open
EQUITY | Sep 18, 2026, 04:04 PM UTC
M
Electra Therapeutics IPO priced at midpoint; raises $350 million
Electra Therapeutics upsized its IPO and priced it at the midpoint of expectations, raising $350 million. Shares are set to debut Friday.
EQUITY | Sep 18, 2026, 09:47 AM UTC
L
ETRA - Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
ETRA - Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
NEWS | Sep 18, 2026, 12:30 AM UTC